These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3461230)

  • 1. [Prevalence of anti-HTLV-III antibodies in blood donors and risk populations in Zaragoza].
    Callén L; Gutiérrez M; Lasierra P; Larrad L
    Med Clin (Barc); 1986 Jun; 87(2):82. PubMed ID: 3461230
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of anti-HTLV-III antibodies in volunteer blood donors in Guipuzcoa].
    Cortés A; Francisco C; Larrañaga MJ; Cárdenas JM
    Med Clin (Barc); 1987 Jan; 88(1):38-9. PubMed ID: 3644127
    [No Abstract]   [Full Text] [Related]  

  • 3. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HTLV-III antibody in American blood donors.
    Schorr JB; Berkowitz A; Cumming PD; Katz AJ; Sandler SG
    N Engl J Med; 1985 Aug; 313(6):384-5. PubMed ID: 3859750
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-HTLV III testing of blood donors and recipients, Hawaii experience.
    Frohlich J
    Hawaii Med J; 1986 Nov; 45(11):391-2. PubMed ID: 3468095
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus development summaries. The impact of routine HTLV-III antibody testing of blood and plasma donors on public health. National Institutes of Health.
    Conn Med; 1986 Nov; 50(11):745-51. PubMed ID: 3466770
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
    Candotti D; Mundy C; Kadewele G; Nkhoma W; Bates I; Allain JP
    J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of anti-HTLV-III testing of volunteer blood donors.
    Grindon AJ
    Beitr Infusionther Klin Ernahr; 1987; 18():1-5. PubMed ID: 3326580
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    Collenberg E; Ouedraogo T; Ganamé J; Fickenscher H; Kynast-Wolf G; Becher H; Kouyaté B; Kräusslich HG; Sangaré L; Tebit DM
    J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of viral antibodies and syphilis serology in blood donors from a hospital].
    Pita-Ramírez L; Torres-Ortiz GE
    Rev Invest Clin; 1997; 49(6):475-80. PubMed ID: 9528308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV screening in Canadian blood donors.
    CMAJ; 1986 Oct; 135(8):901. PubMed ID: 3463387
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of antibodies to human T-lymphotropic type III virus (anti-HTLV III) in a population at high risk for AIDS in Yugoslavia].
    Burek V; Sakoman S; Hudolin V; Kovać D; Ficović P; Cepelja Z; Petricević I; Schönwald S; Soldo I; Borcić D
    Lijec Vjesn; 1987 Jun; 109(6):216-9. PubMed ID: 3477674
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of antibodies to HTLV in blood donors in north London.
    Barbara J; Moore MC; Hewitt PE
    BMJ; 2000 Mar; 320(7235):650. PubMed ID: 10698901
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening blood donors for HTLV-III antibody.
    Mann DA
    JAMA; 1986 Nov; 256(17):2344-5. PubMed ID: 3534328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.